Skip to content

An analysis on risk factors of patients with periodontitis over 5 years after implant restoration

An analysis on risk factors of patients with periodontitis over 5 years after implant restoration

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500104723
Enrollment
Unknown
Registered
2025-06-23
Start date
2025-07-30
Completion date
Unknown
Last updated
2025-06-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periodontitis, peri-implant mucositis, peri-implantitis

Interventions

Peri-implant desease:None

Sponsors

Peking University Hospital of Stomatology
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Periodontal Diagnosis and Treatment: Patients were diagnosed with chronic periodontitis or aggressive periodontitis before implant placement. Completed comprehensive periodontal therapy (e.g., scaling and root planing, periodontal surgery) prior to implant treatment. 2.Implant Restoration Type: The implant-supported restoration consists of either: A single crown, or A fixed dental prosthesis (FDP) with =4 units. 3.Functional Duration: The implant restoration has been in functional use for =5 years post-completion. 4.Complete Clinical Records: Availability of detailed clinical records, including: Pre-implant periodontal therapy, Implant surgical and prosthetic procedures, and Post-restoration follow-up visits. 5.Radiographic Standards: Baseline (restoration completion) and follow-up radiographs were taken using the parallel technique. Image quality meets the standards for radiographic measurements (e.g., clear visualization of implant threads and bone levels).

Exclusion criteria

Exclusion criteria: 1.Medications Affecting Bone Metabolism: Patients on long-term use of medications that may influence bone metabolism, including: Non-steroidal anti-inflammatory drugs (NSAIDs) Bisphosphonates Other bone-modulating agents. 2.Uncontrolled Systemic Conditions that may compromise implant therapy: Diabetes mellitus: HbA1c >7% Hypertension: Uncontrolled hypertension (=180/110 mmHg) Ischemic heart disease: Unstable angina Myocardial infarction within 30 days prior to treatment Cardiac arrhythmias: High-grade atrioventricular block Symptomatic heart failure Infective endocarditis Valvular heart disease.

Design outcomes

Primary

MeasureTime frame
Plaque Index (PI) ;Modified Implant Plaque Index (mIPI);Clinical Probing Depth (PD) ;Implant Probing Depth (IPD);Bleeding Index (BI) ;Peri-implant Bleeding Index (PIBI);Peri-implant Muc;

Countries

China

Contacts

Public ContactJie Han

Peking University Hospital of Stomatology

1265146491@qq.com+86 10 82195368

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026